Ledipasvir
Ledipasvir is a Hepatitis C Virus NS5A Inhibitor. The mechanism of action of ledipasvir is as a P-Glycoprotein Inhibitor, and Breast Cancer Resistance Protein Inhibitor.
| Catalog Number | T6200 |
| Alternative Name(s) | GS-5885 |
| Research Area | Microbiology/Virology|||Proteases/Proteasome |
| Molecular Formula | C49H54F2N8O6 |
| CAS# | 1256388-51-8 |
| Purity | 99.46% |
| SMILES | O=C(OC)N[C@H](C(=O)N1[C@H](c2ncc(c3cc4C(F)(F)c5c(ccc(c6ccc7nc([C@H]8N(C(=O)[C@@H](NC(=O)OC)C(C)C)[C@@H]9CC[C@H]8C9)[nH]c7c6)c5)c4cc3)[nH]2)CC2(C1)CC2)C(C)C |
| Size | 25 mg |
| Supplier Page | https://www.targetmol.com/compound/Ledipasvir |
| Additional Information | https://www.targetmol.com/datasheet/T6200 |